Related references
Note: Only part of the references are listed.The function and regulation of TET2 in innate immunity and inflammation
Boyi Cong et al.
PROTEIN & CELL (2021)
METTL3 regulates heterochromatin in mouse embryonic stem cells
Wenqi Xu et al.
NATURE (2021)
Genome-wide characterization of cytosine-specific 5-hydroxymethylation in normal breast tissue
Owen M. Wilkins et al.
EPIGENETICS (2020)
TET2 deficiency reprograms the germinal center B cell epigenome and silences genes linked to lymphomagenesis
Wojciech Rosikiewicz et al.
SCIENCE ADVANCES (2020)
Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity
Shinya Tanaka et al.
NATURE IMMUNOLOGY (2020)
HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line
Luca Hegedus et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
TET2 promotes anti-tumor immunity by governing G-MDSCs andCD8+T-cell numbers
Shuangqi Li et al.
EMBO REPORTS (2020)
Application of PD-1 Blockade in Cancer Immunotherapy
Xiaomo Wu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer
Takeshi Fukumoto et al.
CANCER RESEARCH (2019)
Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
Yan-ping Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akintunde Akinleye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
Ioannis Zerdes et al.
ONCOGENE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Epigenetic regulators of programmed death-ligand 1 expression in human cancers
Sachin Kumar et al.
TRANSLATIONAL RESEARCH (2018)
DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
Varun Sasidharan Nair et al.
CLINICAL EPIGENETICS (2018)
ERα is a negative regulator of PD-L1 gene transcription in breast cancer
Lu Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Isabel Puig et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta et al.
NATURE (2018)
SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response
Lei-Lei Chen et al.
CELL REPORTS (2018)
TET2 coactivates gene expression through demethylation of enhancers
Lu Wang et al.
SCIENCE ADVANCES (2018)
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression
Wen Pan et al.
IMMUNITY (2017)
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
J. Chen et al.
ANNALS OF ONCOLOGY (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Keisuke Kataoka et al.
NATURE (2016)
A primary role of TET proteins in establishment and maintenance of De Novo bivalency at CpG islands
Lingchun Kong et al.
NUCLEIC ACIDS RESEARCH (2016)
TET3 Inhibits Type I IFN Production Independent of DNA Demethylation
Shengjie Xue et al.
CELL REPORTS (2016)
WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation
Yiping Wang et al.
MOLECULAR CELL (2015)
Structural insight into substrate preference for TET- mediated oxidation
Lulu Hu et al.
NATURE (2015)
Function and information content of DNA methylation
Dirk Schuebeler
NATURE (2015)
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Qian Zhang et al.
NATURE (2015)
Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer
Liu Yang et al.
PLOS ONE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression
Ken-ichi Takayama et al.
NATURE COMMUNICATIONS (2015)
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
David M. Woods et al.
CANCER IMMUNOLOGY RESEARCH (2015)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
H. Yang et al.
LEUKEMIA (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
TET2 promotes histone O-GlcNAcylation during gene transcription
Qiang Chen et al.
NATURE (2013)
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
Myunggon Ko et al.
NATURE (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Genome-wide comparison of DNA hydroxymethylation in mouse embryonic stem cells and neural progenitor cells by a new comparative hMeDIP-seq method
Li Tan et al.
NUCLEIC ACIDS RESEARCH (2013)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Christine Guo Lian et al.
CELL (2012)
Tet family proteins and 5-hydroxymethylcytosine in development and disease
Li Tan et al.
DEVELOPMENT (2012)
5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
Seung-Gi Jin et al.
CANCER RESEARCH (2011)
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green et al.
BLOOD (2010)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Share Paper
